Identification of secretory factors associated with suppressive tumor microenvironment in esophageal cancer

Author:

Liu Jia1,Wang Dong2,Zuo Xianglin3,Zeng Baozhen4,Yin Yin5,Zhang Lu6,Chai Hao7,Shao Lipei7

Affiliation:

1. The First Affiliated Hospital of Nanjing Medical University

2. China Pharmaceutical University

3. Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University

4. Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences

5. The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University

6. Shandong University

7. Nanjing Medical University

Abstract

Abstract Esophageal squamous cell carcinoma (ESCC) is one of the deadliest solid malignancies and has a poor survival rate worldwide. Suppressive tumor microenvironment is the main cause to promote tumor development, metastasis and poor survival time. Tumor-derived secretory factors could connect tumor tissues and components in the tumor microenvironment to promote tumor progression. Here, in our study, we analyzed multiple individual transcriptome databases and found a group of secretory factors derived from tumor tissues that have correlation with infiltrated immune cells in tumor microenvironment. These secretory factors are differently expressed in esophageal tumor tissues compared with adjacent normal tissues. Among them, MFAP2 as the most significant gene was positively correlated with a serial of suppressive infiltrated immune cells, higher pathological stage and poorer overall survival time. Furthermore, we got the consistent results when we collected tissue samples from patients with ESCC and detected the expression of MFAP2 by immunohistochemistry, immunofluorescence and qRT-PCR methods. Our comprehensive analyses deciphered the prognostic, immunological, and therapeutic value of MFAP2 in esophageal cancer management, thus providing a target for individual and precise therapy for combating esophageal cancer.

Publisher

Research Square Platform LLC

Reference35 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA: A Cancer Journal for Clinicians,2018

2. Cancer statistics in China, 2015;Chen W;CA: A Cancer Journal for Clinicians,2016

3. Esophageal carcinoma: long-term survival in consecutive series of patients through a retrospective cohort study;Delpisheh A;Gastroenterology and hepatology from bed to bench,2014

4. Regulation of prostate cancer progression by the tumor microenvironment;Shiao SL;Cancer Letters,2016

5. Understanding the tumor immune microenvironment (TIME) for effective therapy;Binnewies M;Nature medicine,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3